Oragenics, Inc. ( OGEN) - Stock Earnings
OGEN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 16, 2026, midnight | — / — | — | — / — | — |
OGEN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.3 million USD | — USD |
| 2026Q1 | -2.2 million USD | — USD |
| 2026Q2 | -2.5 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
OGEN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -20.7 million USD | 37653 USD |
| 2024 | -10.6 million USD | — USD |
| 2025 | -9.8 million USD | — USD |
| 2026 Est. | — | — |
OGEN
Price: $0.44
52 week price:
Earnings Per Share: -1.43 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 23200
Market Capitalization: 2.3 million